Justin Bowers
Stock Analyst at Deutsche Bank
(1.85)
# 3,291
Out of 5,143 analysts
40
Total ratings
37.5%
Success rate
4.36%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $375 → $315 | $398.33 | -20.92% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $616.35 | -30.23% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $239.52 | +10.64% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $17.62 | +30.53% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $21.63 | +34.07% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $23.17 | +7.90% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $167.42 | -7.42% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $637.89 | -4.37% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $70.65 | +16.07% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $12.31 | +103.17% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.94 | +332.02% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $185.95 | +61.33% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $241.41 | +13.91% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $250.57 | -0.23% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $224.96 | +28.91% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $15.40 | +198.80% | 5 | May 10, 2021 |
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $398.33
Upside: -20.92%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $616.35
Upside: -30.23%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $239.52
Upside: +10.64%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $17.62
Upside: +30.53%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $21.63
Upside: +34.07%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $23.17
Upside: +7.90%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $167.42
Upside: -7.42%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $637.89
Upside: -4.37%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $70.65
Upside: +16.07%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $12.31
Upside: +103.17%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.94
Upside: +332.02%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $185.95
Upside: +61.33%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $241.41
Upside: +13.91%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $250.57
Upside: -0.23%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $224.96
Upside: +28.91%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $15.40
Upside: +198.80%